Intravenous Immune Globulin (IVIG)

DRUG4 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), NYU Langone Health, University of South Florida, Sandeep Jain, MD

Conditions

Autoantibody-associated Heart BlockCongenital Heart BlockDry EyeEnd-Stage Renal DiseaseKidney TransplantationNeonatal LupusSpinocerebellar Ataxias

Early Phase 1

Preventive IVIG Therapy for Congenital Heart Block

CompletedNCT00460928

NYU Langone HealthAutoantibody-associated Heart Block, Congenital Heart Block, Neonatal Lupus

Start: 2007-04-30End: 2009-06-30Updated: 2019-09-30

Phase 1

An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias

University of South FloridaSpinocerebellar Ataxias

Start: 2015-04-30Target: 10Updated: 2016-06-08

IVIG-eye Drops Treatment for Dry Eye Disease

CompletedNCT03992482

Sandeep Jain, MDDry Eye

Start: 2019-05-01End: 2019-08-02Updated: 2020-04-10

Phase 3

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

CompletedNCT00000935

National Institute of Allergy and Infectious Diseases (NIAID)End-Stage Renal Disease, Kidney Transplantation

End: 2003-06-30Target: 100Updated: 2017-01-11